cdmo.directory
← Compare landing

BSP Pharmaceuticals vs WuXi XDC

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/bsppharmaceuticals/wuxi-xdc

CategoryBSP PharmaceuticalsWuXi XDC
Listed sitecdmocdmo
SummaryBSP Pharmaceuticals is a CDMO specializing in development and manufacturing of cytotoxic oncology drugs, ADCs, peptides, proteins, and lipid-based formulations from preclinical GLP through commercial supply.WuXi XDC is a leading CRDMO offering integrated discovery, development, and cGMP manufacturing services for antibody drug conjugates (ADCs) and bioconjugates, with proximately located facilities that reduce development timelines and costs.
Services
  • Formulation Development
  • Process Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Quality Control Testing
  • Technology Transfer
  • Lyophilization (Freeze Drying)
  • Vial Filling
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Oral Solid Dosage Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • ADC Payload & Linker Synthesis
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Peptide Manufacturing
  • Oligonucleotide Manufacturing
  • Lipid Nanoparticle (LNP) Formulation
  • HPAPI Manufacturing (High-Potency)
  • CMC Regulatory Submission Support
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Biologics Development & Manufacturing
  • Bioconjugation Services
  • ADC Payload & Linker Synthesis
  • Recombinant Protein Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • CMC Analytical Development
  • Formulation Development
  • Process Development
  • Technology Transfer
  • Lyophilization (Freeze Drying)
  • Vial Filling
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • Peptide
  • Antibody-Drug Conjugate (ADC)
  • Biologics (Monoclonal Antibodies)
Indications
  • Oncology
  • Immunology
Data not yet provided.
Locations
  • Headquarters and Manufacturing Plant, Latina Scalo, Lazio, Italy
  • Commercial Branch, Princeton, New Jersey, United States
  • Headquarters, China
  • Singapore Site, Singapore, Singapore
Certifications
  • Italian Tax Authority · Identifier: P.IVA/C.F.02314650595
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.